In 2023, China's re-import of sulphonamides was approximately 14.15 thousand kilograms. From 2024 to 2028, the forecasted data reveals a steady decline at a rate of around 3.75% per annum. The compound annual growth rate (CAGR) over these five years indicates a projected reduction of about 2.97% annually. Such trends point to a consistent downtrend in the volume of re-imported sulphonamides, likely influenced by factors such as domestic production capabilities and shifts in demand.
Future trends to watch for include China's efforts to enhance local production efficiency, potential changes in global trade policies, and evolving pharmaceutical regulations that may impact re-import demands.
